Daniel Parera
Analista di Private Equity presso TVM Capital GmbH
Provenienza dei contatti di primo grado di Daniel Parera
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
TVM Capital GmbH
TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management.
15
| Private Company | Investment Managers | 15 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Daniel Parera tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
EVOTEC SE | Pharmaceuticals: Major | Director/Board Member | |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
Globespan Capital Management LLC
Globespan Capital Management LLC Investment ManagersFinance Globespan Capital Management LLC (Globespan Cap Partners) is a venture capital firm founded in 2003 by Barry J. Schiffman and Andy P. Goldfarb. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Director of Finance/CFO | |
Boston College | College/University | Undergraduate Degree | |
Concordia University | College/University | Undergraduate Degree | |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chairman | |
INSEAD | College/University | Masters Business Admin | |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Euronext Paris SA
Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Investment Banks/Brokers | Director/Board Member | |
SelectX Pharmaceuticals, Inc.
SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
University of Passau | College/University | Graduate Degree | |
King Saud University | College/University | Graduate Degree | |
VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
Ambu Innovation GmbH
Ambu Innovation GmbH Medical SpecialtiesHealth Technology Ambu Innovation GmbH engages in the development and distribution of single-use and light-weight robotically-assisted high definition endoscopy products in the field of gastroenterology and gastro-intestinal surgery. Its products include invendoscope SC210, invendo ScopeController, and invendo SPU E210. The company was founded in 1992 and is headquartered in Kissing, Germany. | Medical Specialties | Director/Board Member | |
DIREVO Industrial Biotechnology GmbH
DIREVO Industrial Biotechnology GmbH Miscellaneous Commercial ServicesCommercial Services DIREVO Industrial Biotechnology GmbH provides bioengineering services for industrial, molecular biology, and reaction chemistry applications. It offers enzyme and strain engineering, application development, and process engineering services. The firm also offers research and development services for bio-fuel production. The company was founded in July 2008 and is headquartered in Cologne, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Harvard Medical School | College/University | Doctorate Degree | |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
TiE Boston
TiE Boston Investment ManagersFinance TiE Boston is a private equity firm founded by by Desh Deshpande in 1997. The firm is headquartered in Boston, MA. | Investment Managers | Director/Board Member | |
Credit Sesame, Inc.
Credit Sesame, Inc. Finance/Rental/LeasingFinance Credit Sesame, Inc. engages in the design and development of personal financial management tools. The firm operates an online credit and loans analytics engine. It provides a complete picture of its credit and loans in one place, including its credit score, credit monitoring, personalized financing analysis, and pre-qualified loan and savings recommendations. The company was founded by Adrian A. Nazari and Sean Donn in 2010 and is headquartered in Mountain View, CA. | Finance/Rental/Leasing | Director/Board Member | |
NATIONAL MEDICAL CARE COMPANY | Hospital/Nursing Management | Chief Executive Officer | |
Causeway Management LLC
Causeway Management LLC Investment ManagersFinance Causeway Management LLC (Causeway Media Partners) is a venture capital firm founded in 2013 by Wycliffe K Grousbeck, Mark Allen Wan and Bob F Higgins. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Director of Finance/CFO | |
Harvard Business School | College/University | Masters Business Admin | |
SpePharm AG
SpePharm AG Pharmaceuticals: MajorHealth Technology SpePharm AG acquires, registers, and markets medical value medicines for the hospital sector. Its brands include Dantrium IV, Dantrium, Dantamacrin, Lymphoseek and Mugard. The company was founded in 2012 and is headquartered in Luzern, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Centogene AG
Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Medical/Nursing Services | Director/Board Member | |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Pharmaceuticals: MajorHealth Technology leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member | |
TME PHARMA N.V. | Biotechnology | Chairman | |
Charité Research Organisation GmbH
Charité Research Organisation GmbH Miscellaneous Commercial ServicesCommercial Services Charité Research Organisation GmbH is a contract research organization that helps clients move development projects from first time in human to proof of concept as quickly and efficiently as possible. The private company is based in Berlin, Germany and was founded in 2005 by Frank Wagner, who has been the CEO since then. Charité Research Organisation offers scientific and regulatory consultancy, protocol development, routine laboratory, biomarker laboratory, imaging, project management, monitoring, data management, biostatistics, and medical writing services. The German company also provides world-leading patient and healthy volunteer recruitment capabilities and delivers the best value solution for early clinical development. | Miscellaneous Commercial Services | Director/Board Member | |
AL-S Pharma AG
AL-S Pharma AG Pharmaceuticals: MajorHealth Technology AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Chairman | |
ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
TVM V LSV Beteiligungsgesellschaft mbH
TVM V LSV Beteiligungsgesellschaft mbH Financial ConglomeratesFinance TVM V LSV Beteiligungsgesellschaft mbH provides investment services. The private company is based in Munich, Germany. The CEOs are Stefan Fischer, Josef Moosholzer. The German company was founded in 2001. | Financial Conglomerates | Chief Executive Officer | |
TVM IV Beteiligungsgesellschaft mbH
TVM IV Beteiligungsgesellschaft mbH Miscellaneous Commercial ServicesCommercial Services TVM IV Beteiligungsgesellschaft mbH provides professional, scientific, and technical services. The private company is based in Munich, Germany. The CEOs are Stefan Fischer, Josef Moosholzer. The German company was founded in 2000. | Miscellaneous Commercial Services | Chief Executive Officer | |
Kurma Partners /DE/ | Investment Managers | Private Equity Investor | |
CENTOGENE N.V. | Miscellaneous Commercial Services | Director/Board Member | |
TACALYX GmbH
TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services TACALYX GmbH engages in the discovery and development of Tumor Associated Carbohydrate Antigenantibodies to treat cancer. The company was founded by Peter Sondermann, Peter H. Seeberger, and Oren Moscovitz and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Synendos Therapeutics AG
Synendos Therapeutics AG Medical SpecialtiesHealth Technology Synendos Therapeutics AG develops molecules for the treatment of anxiety and stress-related disorders. The company was founded by Andrea Chicca, Simon Russell and Jürg Gertsch in April 2019 and is headquartered in Allschwil, Switzerland. | Medical Specialties | Director/Board Member | |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Chairman | |
TVM Healthcare Advisors LLC | Investment Managers | Private Equity Investor | |
Zeneca AGro Gmbh | Sales & Marketing | ||
TVM Life Science Management GmbH
TVM Life Science Management GmbH Miscellaneous Commercial ServicesCommercial Services Part of TVM Capital GmbH, TVM Life Science Management GmbH provides management services. The company is based in Munich, Germany. The CEO of the German company is Stefan Fischer. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer |
Statistiche
Distribuzione geografica
Germania | 22 |
Stati Uniti | 15 |
Svizzera | 5 |
Francia | 4 |
Arabia Saudita | 4 |
Settori
Health Technology | 23 |
Finance | 10 |
Consumer Services | 9 |
Commercial Services | 8 |
Health Services | 3 |
Posizioni
Director/Board Member | 53 |
Chairman | 23 |
Private Equity Investor | 14 |
Corporate Officer/Principal | 9 |
Chief Executive Officer | 7 |
Contatti più connessi
Insiders | |
---|---|
Helmut Schühsler | 28 |
Hubert Birner | 27 |
Alexandra Goll | 14 |
Jochen Knolle | 11 |
Peter Neubeck | 10 |
Stefan Fischer | 8 |
Dave Poltack | 7 |
Othman Abdullah Aba Hussein | 5 |
Monika Schlesinger | 1 |
Hui-Hsing Ma | 1 |
Robert Schneider | 1 |
Rolf Starck | 1 |
Sascha Berger | 1 |
Catello Somma | 1 |
Philipp Lechner | 1 |
- Borsa valori
- Insiders
- Daniel Parera
- Connessioni Società